Published On: Wed, Nov 1st, 2017

This Weeks Target Prices For Tandem Diabetes Care, Inc. (TNDM)


Recently stock market analysts have updated their consensus ratings on shares of Tandem Diabetes Care, Inc. (TNDM).

Most recent broker ratings

04/10/2017 – Tandem Diabetes Care, Inc. was downgraded to “market perform” by analysts at Cowen. They now have a USD 1.5 price target on the stock.

03/30/2017 – Tandem Diabetes Care, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray.

03/24/2017 – Tandem Diabetes Care, Inc. was downgraded to “neutral” by analysts at B. Riley. They now have a USD 1.5 price target on the stock.

11/02/2016 – Tandem Diabetes Care, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 9 price target on the stock.

11/02/2016 – Tandem Diabetes Care, Inc. was downgraded to “hold” by analysts at Stifel Nicolaus. They now have a USD 3.5 price target on the stock.

11/02/2016 – Tandem Diabetes Care, Inc. was downgraded to “neutral” by analysts at Robert W. Baird. They now have a USD 4 price target on the stock.

11/02/2016 – Tandem Diabetes Care, Inc. was downgraded to “buy” by analysts at Feltl & Co..

03/24/2016 – Tandem Diabetes Care, Inc. was downgraded to “underperform” by analysts at Bank of America Merrill Lynch.

10/21/2015 – Tandem Diabetes Care, Inc. had its “market perform” rating reiterated by analysts at William Blair.

05/01/2015 – Tandem Diabetes Care, Inc. was upgraded to “buy” by analysts at Zacks. They now have a USD 15 price target on the stock.

11/04/2014 – Northcoast Research began new coverage on Tandem Diabetes Care, Inc. giving the company a “buy” rating.

10/27/2014 – Wedbush began new coverage on Tandem Diabetes Care, Inc. giving the company a “outperform” rating.

03/07/2014 – EVA Dimensions began new coverage on Tandem Diabetes Care, Inc. giving the company a “underweight” rating.

Tandem Diabetes Care, Inc. has a 50 day moving average of 4.97 and a 200 day moving average of 6.98. The stock’s market capitalization is 12.40M, it has a 52-week low of 2.27 and a 52-week high of 44.00.

The share price of the company (TNDM) was down -2.76% during the last trading session, with a high of 2.53 and the volume of Tandem Diabetes Care, Inc. shares traded was 420907.

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.